Table 3.

Results and characteristics of patients with liver metastasis

Patient	Primary cancer	Non-tumor tissue					Tumor tissue
		Fibrosis	Methylight		MSP	IRS	Methylight		MSP	IRS
		score	Result	PMR			Result	PMR
Liver metastasis (M)
M1	breast	1	neg	0.05	nd	3	neg	0.02	nd	6
M2	breast	0	neg	0.04	nd	2	neg	0.01	nd	6
M3	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	4
M4	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	6
M5	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	3
M6	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	6
M7	colorectal	4	neg	0.01	nd	0	neg	0.01	nd	5
M8	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	5
M9	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	6
M10	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	5
M11	colorectal	0	neg	0.01	nd	2	pos	39.55	nd	4
M12	colorectal	0	neg	0.01	nd	0	neg	0.01	nd	6
M13	colorectal	0	neg	0.01	neg	0	neg	0.01	neg	6
M14	colorectal	0	neg	0.02	pos	0	neg	0.01	pos	6
M15	colorectal	0	neg	0.01	neg	0	pos	52.18	neg	6
M16	colorectal	0	neg	0.09	neg	0	neg	0.74	neg	6
M17	colorectal	0	neg	0.39	neg	2	neg	0.04	neg	6
M18	colorectal	0	neg	0.73	neg	0	neg	0.12	neg	5
M19	colorectal	0	neg	0.15	neg	0	neg	0.01	neg	5
M20	colorectal	0	neg	0.17	pos	2	neg	0.01	neg	4
M21	colorectal	0	neg	0.8	neg	3	pos	57.82	pos	0
M22	colorectal	0	neg	0.54	pos	2	neg	0.35	neg	5
M23	colorectal	2	neg	0.55	pos	0	neg	0.51	neg	6
M24	colorectal	0	neg	0.38	neg	0	pos	9.88	pos	0
M25	colorectal	0	neg	0.08	pos	0	pos	6.48	neg	5
M26	gastric	0	neg	0.01	pos	nd	neg	0.01	neg	nd
M27	gastric	0	neg	0.39	neg	nd	neg	0.15	neg	nd
M28	colorectal	0	neg	0.09	neg	nd	pos	25.19	neg	nd
M29	colorectal	0	neg	0.85	pos	nd	neg	0.07	pos	nd
M30	colorectal	0	neg	0.86	neg	nd	neg	0.49	neg	nd
M31	colorectal	0	neg	0.55	pos	nd	neg	1.19	pos	nd
M32	renal	0	neg	0.01	nd	nd	neg	0.01	nd	nd
M33	colorectal	1	neg	0.08	nd	nd	neg	0.85	nd	nd
M34	colorectal	0	neg	0.03	nd	nd	neg	0.01	nd	nd

PMR, percentage of methylated reference (%); MSP, methylation specific PCR; nd, not done;